Drug Profile
TK 88
Alternative Names: TK-88Latest Information Update: 28 Feb 2022
Price :
$50
*
At a glance
- Originator Tosk
- Class Chemoprotectants; Neuroprotectants; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Hearing loss; Kidney disorders; Peripheral nervous system diseases
Most Recent Events
- 28 Feb 2022 No recent reports of development identified for preclinical development in Hearing loss in USA
- 28 Feb 2022 No recent reports of development identified for preclinical development in Kidney-disorders in USA
- 28 Feb 2022 No recent reports of development identified for preclinical development in Peripheral-nervous-system-diseases in USA